Works by Espié, Marc

Results: 37

Use of iron sucrose and red blood cell transfusions in anaemic cancer patients in France (OncoFer study).

Published in:

2017

By:

Luporsi, Elisabeth;
Toledano, Alain;
Spaeth, Dominique;
Scotté, Florian;
Espié, Marc;
Perot, Stéphanie;
Duvillié, Ladan;
Pithois Merli, Isabelle;
Bugat, Roland;
Scotté, Florian;
Espié, Marc;
Perot, Stéphanie;
Duvillié, Ladan

Publication type:

journal article

Nonpalpable breast lesions: impact of a second-opinion review at a breast unit on BI-RADS classification.

Published in:

European Radiology, 2021, v. 31, n. 8, p. 5913, doi. 10.1007/s00330-020-07664-1

By:

de Margerie-Mellon, Constance;
Debry, Jean-Baptiste;
Dupont, Axelle;
Cuvier, Caroline;
Giacchetti, Sylvie;
Teixeira, Luis;
Espié, Marc;
de Bazelaire, Cédric

Publication type:

Article

Diffusion-weighted MRI in pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer.

Published in:

European Radiology, 2013, v. 23, n. 9, p. 2420, doi. 10.1007/s00330-013-2850-x

By:

Richard, Raphael;
Thomassin, Isabelle;
Chapellier, Marion;
Scemama, Aurélie;
Cremoux, Patricia;
Varna, Mariana;
Giacchetti, Sylvie;
Espié, Marc;
Kerviler, Eric;
Bazelaire, Cedric

Publication type:

Article

18F-FDG PET/CT for the Early Evaluation of Response to Neoadjuvant Treatment in Triple-Negative Breast Cancer: Influence of the Chemotherapy Regimen.

Published in:

Journal of Nuclear Medicine, 2016, v. 57, n. 4, p. 536, doi. 10.2967/jnumed.115.163907

By:

Groheux, David;
Biard, Lucie;
Giacchetti, Sylvie;
Teixeira, Luis;
Hindié, Elif;
Cuvier, Caroline;
Vercellino, Laetitia;
Merlet, Pascal;
de Roquancourt, Anne;
de Cremoux, Patricia;
Resche-Rigon, Matthieu;
Espié, Marc

Publication type:

Article

Baseline Tumor 18F-FDG Uptake and Modifications After 2 Cycles of Neoadjuvant Chemotherapy Are Prognostic of Outcome in ER+/HER2- Breast Cancer.

Published in:

Journal of Nuclear Medicine, 2015, v. 56, n. 6, p. 824, doi. 10.2967/jnumed.115.154138

By:

Groheux, David;
Sanna, Alice;
Majdoub, Mohamed;
de Cremoux, Patricia;
Giacchetti, Sylvie;
Teixeira, Luis;
Espié, Marc;
Merlet, Pascal;
de Roquancourt, Anne;
Visvikis, Dimitris;
Hatt, Mathieu;
Resche-Rigon, Matthieu;
Hindié, Elif

Publication type:

Article

Comparison Between 18F-FDG PET Image--Derived Indices for Early Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer.

Published in:

Journal of Nuclear Medicine, 2013, v. 54, n. 3, p. 341, doi. 10.2967/jnumed.112.108837

By:

Hatt, Mathieu;
Groheux, David;
Martineau, Antoine;
Espié, Marc;
Hindié, Elif;
Giacchetti, Sylvie;
de Roquancourt, Anne;
Visvikis, Dimitris;
Rest, Catherine Cheze-Le

Publication type:

Article

18F-FDG PET/CT in Staging Patients with Locally Advanced or Inflammatory Breast Cancer: Comparison to Conventional Staging.

Published in:

Journal of Nuclear Medicine, 2013, v. 54, n. 1, p. 5, doi. 10.2967/jnumed.112.106864

By:

Groheux, David;
Giacchetti, Sylvie;
Delord, Marc;
Hindié, Elif;
Vercellino, Laetitia;
Cuvier, Caroline;
Toubert, Marie-Elisabeth;
Merlet, Pascal;
Hennequin, Christophe;
Espié, Marc

Publication type:

Article

Triple-Negative Breast Cancer: Early Assessment with 18F-FDG PET/CT During Neoadjuvant Chemotherapy Identifies Patients Who Are Unlikely to Achieve a Pathologic Complete Response and Are at a High Risk of Early Relapse.

Published in:

Journal of Nuclear Medicine, 2012, v. 53, n. 2, p. 249, doi. 10.2967/jnumed.111.094045

By:

Groheux, David;
Hindié, Elif;
Giacchetti, Sylvie;
Delord, Marc;
Hamy, Anne-Sophie;
de Roquancourt, Anne;
Vercellino, Laetitia;
Berenger, Nathalie;
Marty, Michel;
Espié, Marc

Publication type:

Article

The Yield of 18F-FDG PET/CT in Patients with Clinical Stage IIA, IIB, or IIIA Breast Cancer: A Prospective Study.

Published in:

Journal of Nuclear Medicine, 2011, v. 52, n. 10, p. 1526, doi. 10.2967/jnumed.111.093864

By:

Groheux, David;
Giacchetti, Sylvie;
Espié, Marc;
Vercellino, Laetitia;
Hamy, Anne-Sophie;
Delord, Marc;
Berenger, Nathalie;
Toubert, Marie-Elisabeth;
Misset, Jean-Louis;
Hindié, Elif

Publication type:

Article

The Sentinel Node Procedure in Breast Cancer: Nuclear Medicine as the Starting Point.

Published in:

Journal of Nuclear Medicine, 2011, v. 52, n. 3, p. 405, doi. 10.2967/jnumed.110.081711

By:

Hindié, Elif;
Groheux, David;
Brenot-Rossi, Isabelle;
Rubello, Domenico;
Moretti, Jean-Luc;
Espié, Marc

Publication type:

Article

Cyclophosphamide Dose Intensification May Circumvent Anthracycline Resistance of p53 Mutant Breast Cancers.

Published in:

Oncologist, 2010, v. 15, n. 3, p. 246, doi. 10.1634/theoncologist.2009-0243

By:

Lehmann-Che, Jacqueline;
André, Fabrice;
Desmedt, Christine;
Mazouni, Chafika;
Giacchetti, Sylvie;
Turpin, Elisabeth;
Espié, Marc;
Plassa, Louis-François;
Marty, Michel;
Bertheau, Philippe;
Sotiriou, Christos;
Piccart, Martine;
Symmans, W. Fraser;
Pusztai, Lajos;
de Thé, Hugues

Publication type:

Article

Incidence, risk factors, and outcomes of central venous catheter-related thromboembolism in breast cancer patients: the CAVECCAS study.

Published in:

Cancer Medicine, 2017, v. 6, n. 11, p. 2732, doi. 10.1002/cam4.1201

By:

Debourdeau, Philippe;
Espié, Marc;
Chevret, Sylvie;
Gligorov, Joseph;
Elias, Antoine;
Dupré, Pierre François;
Desseaux, Kristell;
Kalidi, Issa;
Villiers, Stephane;
Giachetti, Sylvie;
Frere, Corinne;
Farge, Dominique

Publication type:

Article

TP53 Status and Response to Chemotherapy in Breast Cancer.

Published in:

Pathobiology, 2008, v. 75, n. 2, p. 132, doi. 10.1159/000123851

By:

Bertheau, Philippe;
Espié, Marc;
Turpin, Elisabeth;
Lehmann, Jacqueline;
Plassa, Louis-François;
Varna, Mariana;
Janin, Anne;
de Thé, Hugues

Publication type:

Article

Correlation between tumour characteristics, SUV measurements, metabolic tumour volume, TLG and textural features assessed with F-FDG PET in a large cohort of oestrogen receptor-positive breast cancer patients.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 7, p. 1145, doi. 10.1007/s00259-017-3641-4

By:

Lemarignier, Charles;
Martineau, Antoine;
Teixeira, Luis;
Vercellino, Laetitia;
Espié, Marc;
Merlet, Pascal;
Groheux, David

Publication type:

Article

F-FDG PET/CT in the early prediction of pathological response in aggressive subtypes of breast cancer: review of the literature and recommendations for use in clinical trials.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2016, v. 43, n. 5, p. 983, doi. 10.1007/s00259-015-3295-z

By:

Groheux, David;
Mankoff, David;
Espié, Marc;
Hindié, Elif

Publication type:

Article

Do clinical, histological or immunohistochemical primary tumour characteristics translate into different F-FDG PET/CT volumetric and heterogeneity features in stage II/III breast cancer?

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2015, v. 42, n. 11, p. 1682, doi. 10.1007/s00259-015-3110-x

By:

Groheux, David;
Majdoub, Mohamed;
Tixier, Florent;
Rest, Catherine;
Martineau, Antoine;
Merlet, Pascal;
Espié, Marc;
Roquancourt, Anne;
Hindié, Elif;
Hatt, Mathieu;
Visvikis, Dimitris

Publication type:

Article

Single-Agent Gemcitabine Is Active in Previously Treated Metastatic Breast Cancer.

Published in:

Oncology, 2001, v. 60, n. 4, p. 303, doi. 10.1159/000058524

By:

Spielmann, Marc;
Llombart-Cussac, Antonio;
Kalla, Salima;
Espié, Marc;
Namer, Moïse;
Ferrero, Jean-Marc;
Diéras, Véronique;
Fumoleau, Pierre;
Cuvier, Caroline;
Perrocheau, Geneviève;
Ponzio, Anne;
Kayitalire, Louis;
Pouillart, Pierre

Publication type:

Article

Intraoperative Radiotherapy for Breast Cancer in Elderly Women.

Published in:

2022

By:

Guillerm, S Ophie;
Bourstyn, Edwige;
Itti, Ramona;
Cahen-Doidy, Laurence;
Quéro, Laurent;
Labidi, Mouna;
Marchand, Eva;
Lorphelin, Henri;
Giacchetti, Sylvie;
Cuvier, Caroline;
Espié, Marc;
Teixeira, Luis;
Hennequin, Christophe

Publication type:

journal article

A multicenter randomized phase II study of sequential epirubicin/cyclophosphamide followed by docetaxel with or without celecoxib or trastuzumab according to HER2 status, as primary chemotherapy for localized invasive breast cancer patients.

Published in:

Breast Cancer Research & Treatment, 2010, v. 122, n. 2, p. 429, doi. 10.1007/s10549-010-0939-3

By:

Pierga, Jean-Yves;
Delaloge, Suzette;
Espié, Marc;
Brain, Etienne;
Sigal-Zafrani, Brigitte;
Mathieu, Marie-Christine;
Bertheau, Philippe;
Guinebretière, Jean;
Spielmann, Marc;
Savignoni, Alexia;
Marty, Michel

Publication type:

Article

Early monitoring of response to neoadjuvant chemotherapy in breast cancer with F-FDG PET/CT: defining a clinical aim.

Published in:

2011

By:

Groheux, David;
Giacchetti, Sylvie;
Espié, Marc;
Rubello, Domenico;
Moretti, Jean-luc;
Hindié, Elif

Publication type:

Editorial

Correlation of high F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2011, v. 38, n. 3, p. 426, doi. 10.1007/s00259-010-1640-9

By:

Groheux, David;
Giacchetti, Sylvie;
Moretti, Jean-Luc;
Porcher, Raphael;
Espié, Marc;
Lehmann-Che, Jacqueline;
Roquancourt, Anne;
Hamy, Anne-Sophie;
Cuvier, Caroline;
Vercellino, Laetitia;
Hindié, Elif

Publication type:

Article

Should FDG PET/CT be used for the initial staging of breast cancer?

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2009, v. 36, n. 10, p. 1539, doi. 10.1007/s00259-009-1159-0

By:

Groheux, David;
Hindié, Elif;
Rubello, Domenico;
Espié, Marc;
Baillet, Georges;
Giacchetti, Sylvie;
Misset, Jean-Louis;
Moretti, Jean-Luc

Publication type:

Article

Prognostic Impact of Stromal Immune Infiltration before and after Neoadjuvant Chemotherapy (NAC) in Triple Negative Inflammatory Breast Cancers (TNIBC) Treated with Dose-Dense Dose-Intense NAC.

Published in:

Cancers, 2020, v. 12, n. 9, p. 2657, doi. 10.3390/cancers12092657

By:

Campedel, Luca;
Blanc-Durand, Paul;
Bin Asker, Asker;
Lehmann-Che, Jacqueline;
Cuvier, Caroline;
De Bazelaire, Cedric;
Teixeira, Luis;
Becourt, Stephanie;
Ledoux, Florence;
Hocini, Hamid;
Bourstyn, Edwige;
Miquel, Catherine;
Guillerm, Sophie;
Charveriat, Patrick;
Espié, Marc;
De Roquancourt, Anne;
Hamy, Anne-Sophie;
Giacchetti, Sylvie

Publication type:

Article

Distinct tumor protein p53 mutants in breast cancer subgroups.

Published in:

International Journal of Cancer, 2013, v. 132, n. 5, p. 1227, doi. 10.1002/ijc.27767

By:

Dumay, Anne;
Feugeas, Jean‐Paul;
Wittmer, Evelyne;
Lehmann‐Che, Jacqueline;
Bertheau, Philippe;
Espié, Marc;
Plassa, Louis‐François;
Cottu, Paul;
Marty, Michel;
André, Fabrice;
Sotiriou, Christos;
Pusztai, Lajos;
de Thé, Hugues

Publication type:

Article

Estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast tumors: early prediction of chemosensitivity with (18)F-fluorodeoxyglucose positron emission tomography/computed tomography during neoadjuvant chemotherapy.

Published in:

2013

By:

Groheux, David;
Hatt, Mathieu;
Hindié, Elif;
Giacchetti, Sylvie;
de Cremoux, Patricia;
Lehmann-Che, Jacqueline;
Martineau, Antoine;
Marty, Michel;
Cuvier, Caroline;
Cheze-Le Rest, Catherine;
de Roquancourt, Anne;
Visvikis, Dimitris;
Espié, Marc

Publication type:

journal article

Estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast tumors.

Published in:

Cancer (0008543X), 2013, v. 119, n. 11, p. 1960, doi. 10.1002/cncr.28020

By:

Groheux, David;
Hatt, Mathieu;
Hindié, Elif;
Giacchetti, Sylvie;
de Cremoux, Patricia;
Lehmann‐Che, Jacqueline;
Martineau, Antoine;
Marty, Michel;
Cuvier, Caroline;
Cheze‐Le Rest, Catherine;
de Roquancourt, Anne;
Visvikis, Dimitris;
Espié, Marc

Publication type:

Article

Negative Relationship between Post-Treatment Stromal Tumor-Infiltrating Lymphocyte (TIL) and Survival in Triple-Negative Breast Cancer Patients Treated with Dose-Dense Dose-Intense NeoAdjuvant Chemotherapy.

Published in:

Cancers, 2022, v. 14, n. 5, p. 1331, doi. 10.3390/cancers14051331

By:

Giacchetti, Sylvie;
Faucheux, Lilith;
Gardair, Charlotte;
Cuvier, Caroline;
de Roquancourt, Anne;
Campedel, Luca;
Groheux, David;
de Bazelaire, Cedric;
Lehmann-Che, Jacqueline;
Miquel, Catherine;
Cahen Doidy, Laurence;
Amellou, Malika;
Madelaine, Isabelle;
Reyal, Fabien;
Someil, Laetitia;
Hocini, Hamid;
Hennequin, Christophe;
Teixeira, Luis;
Espié, Marc;
Chevret, Sylvie

Publication type:

Article

Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15.

Published in:

Breast Cancer Research, 2013, v. 15, n. 3, p. 1, doi. 10.1186/bcr3421

By:

Lehmann-Che, Jacqueline;
Hamy, Anne-Sophie;
Porcher, Raphaël;
Barritault, Marc;
Bouhidel, Fatiha;
Habuellelah, Hanadi;
Leman-Detours, Solenne;
Roquancourt, Anne de;
Cahen-Doidy, Laurence;
Bourstyn, Edwige;
Cremoux, Patricia de;
Bazelaire, Cedric de;
Albiter, Marcela;
Giacchetti, Sylvie;
Cuvier, Caroline;
Janin, Anne;
Espié, Marc;
Thé, Hugues de;
Bertheau, Philippe

Publication type:

Article

Unveiling Neoadjuvant Therapy: Insights and Outlooks for HER2-Positive Early Breast Cancer.

Published in:

Current Treatment Options in Oncology, 2024, v. 25, n. 9, p. 1225, doi. 10.1007/s11864-024-01252-x

By:

Bischoff, Hervé;
Espié, Marc;
Petit, Thierry

Publication type:

Article

Neoadjuvant Therapy: Current Landscape and Future Horizons for ER-Positive/HER2-Negative and Triple-Negative Early Breast Cancer.

Published in:

Current Treatment Options in Oncology, 2024, v. 25, n. 9, p. 1210, doi. 10.1007/s11864-024-01251-y

By:

Bischoff, Hervé;
Espié, Marc;
Petit, Thierry

Publication type:

Article

Prospective analysis of the impact of VEGF-A gene polymorphisms on the pharmacodynamics of bevacizumab-based therapy in metastatic breast cancer patients.

Published in:

British Journal of Clinical Pharmacology, 2011, v. 71, n. 6, p. 921, doi. 10.1111/j.1365-2125.2010.03896.x

By:

Etienne-Grimaldi, Marie-Christine;
Formento, Patricia;
Degeorges, Armelle;
Pierga, Jean-Yves;
Delva, Rémi;
Pivot, Xavier;
Dalenc, Florence;
Espié, Marc;
Veyret, Corinne;
Formento, Jean-Louis;
Francoual, Mireille;
Piutti, Magali;
de Crémoux, Patricia;
Milano, Gérard

Publication type:

Article

Final results of the double-blind placebo-controlled randomized phase 2 LOTUS trial of first-line ipatasertib plus paclitaxel for inoperable locally advanced/metastatic triple-negative breast cancer.

Published in:

Breast Cancer Research & Treatment, 2021, v. 189, n. 2, p. 377, doi. 10.1007/s10549-021-06143-5

By:

Dent, Rebecca;
Oliveira, Mafalda;
Isakoff, Steven J.;
Im, Seock-Ah;
Espié, Marc;
Blau, Sibel;
Tan, Antoinette R.;
Saura, Cristina;
Wongchenko, Matthew J.;
Xu, Na;
Bradley, Denise;
Reilly, Sarah-Jayne;
Mani, Aruna;
Kim, Sung-Bae;
on behalf of the LOTUS investigators;
Lee, K. S.;
Sohn, J. H.;
Kim, J. H.;
Seo, J. H.;
Kim, J. S.

Publication type:

Article

Prognostic Impact of 18FDG-PET-CT Findings in Clinical Stage III and IIB Breast Cancer.

Published in:

JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 24, p. 1879, doi. 10.1093/jnci/djs451

By:

Groheux, David;
Hinde, Elif;
Delord, Marc;
Giacchetti, Sylvie;
Hamy, Anne-sophie;
de Bazelaire, Cedric;
de Roquancourt, Anne;
Vercellino, Laetitia;
Toubert, Marie-Elisabeth;
Merlet, Pascal;
Espié, Marc

Publication type:

Article

Breast cancer incidence and hormone replacement therapy: Results from the MISSION study, prospective phase.

Published in:

Gynecological Endocrinology, 2007, v. 23, n. 7, p. 391, doi. 10.1080/09513590701382104

By:

Espié, Marc;
Daures, Jean-Pierre;
Chevallier, Thierry;
Mares, Pierre;
Micheletti, Marie-Christine;
de Reilhac, Pia

Publication type:

Article

Breast cancer in postmenopausal women with and without hormone replacement therapy: Preliminary results of the MISSION study

Published in:

Gynecological Endocrinology, 2006, v. 22, n. 8, p. 423, doi. 10.1080/09513590600900386

By:

Espié, Marc;
Mares, Pierre;
de Reilhac, Pia;
Chevallier, Thierry;
Daurès, Jean-Pierre

Publication type:

Article

Actionability of HER2-amplified circulating tumor cells in HER2-negative metastatic breast cancer: the CirCe T-DM1 trial.

Published in:

2019

By:

Jacot, William;
Cottu, Paul;
Berger, Frederique;
Dubot, Coraline;
Venat-Bouvet, Laurence;
Lortholary, Alain;
Bourgeois, Hugues;
Bollet, Marc;
Servent, Veronique;
Luporsi, Elisabeth;
Espié, Marc;
Guiu, Severine;
D'Hondt, Veronique;
Dieras, Veronique;
Sablin, Marie-Paule;
Brain, Etienne;
Neffati, Souhir;
Pierga, Jean-Yves;
Bidard, Francois-Clement

Publication type:

journal article

Expression of amphiregulin and epidermal growth factor receptor in human breast cancer: analysis of autocriny and stromal-epithelial interactions.

Published in:

Journal of Pathology, 2001, v. 194, n. 4, p. 413, doi. 10.1002/path.902

By:

Ma, Lin;
de Roquancourt, Anne;
Bertheau, Philippe;
Chevret, Sylvie;
Millot, Guy;
Sastre-Garau, Xavier;
Espié, Marc;
Marty, Michel;
Janin, Anne;
Calvo, Fabien

Publication type:

Article

Works by Espié, Marc

Use of iron sucrose and red blood cell transfusions in anaemic cancer patients in France (OncoFer study).

Nonpalpable breast lesions: impact of a second-opinion review at a breast unit on BI-RADS classification.

Diffusion-weighted MRI in pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer.

<sup>18</sup>F-FDG PET/CT for the Early Evaluation of Response to Neoadjuvant Treatment in Triple-Negative Breast Cancer: Influence of the Chemotherapy Regimen.

Baseline Tumor <sup>18</sup>F-FDG Uptake and Modifications After 2 Cycles of Neoadjuvant Chemotherapy Are Prognostic of Outcome in ER+/HER2- Breast Cancer.

Comparison Between <sup>18</sup>F-FDG PET Image--Derived Indices for Early Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer.

<sup>18</sup>F-FDG PET/CT in Staging Patients with Locally Advanced or Inflammatory Breast Cancer: Comparison to Conventional Staging.

Triple-Negative Breast Cancer: Early Assessment with <sup>18</sup>F-FDG PET/CT During Neoadjuvant Chemotherapy Identifies Patients Who Are Unlikely to Achieve a Pathologic Complete Response and Are at a High Risk of Early Relapse.

The Yield of <sup>18</sup>F-FDG PET/CT in Patients with Clinical Stage IIA, IIB, or IIIA Breast Cancer: A Prospective Study.

The Sentinel Node Procedure in Breast Cancer: Nuclear Medicine as the Starting Point.

Cyclophosphamide Dose Intensification May Circumvent Anthracycline Resistance of p53 Mutant Breast Cancers.

Incidence, risk factors, and outcomes of central venous catheter-related thromboembolism in breast cancer patients: the CAVECCAS study.

TP53 Status and Response to Chemotherapy in Breast Cancer.

Correlation between tumour characteristics, SUV measurements, metabolic tumour volume, TLG and textural features assessed with F-FDG PET in a large cohort of oestrogen receptor-positive breast cancer patients.

F-FDG PET/CT in the early prediction of pathological response in aggressive subtypes of breast cancer: review of the literature and recommendations for use in clinical trials.

Do clinical, histological or immunohistochemical primary tumour characteristics translate into different F-FDG PET/CT volumetric and heterogeneity features in stage II/III breast cancer?

Single-Agent Gemcitabine Is Active in Previously Treated Metastatic Breast Cancer.

Intraoperative Radiotherapy for Breast Cancer in Elderly Women.

A multicenter randomized phase II study of sequential epirubicin/cyclophosphamide followed by docetaxel with or without celecoxib or trastuzumab according to HER2 status, as primary chemotherapy for localized invasive breast cancer patients.

Early monitoring of response to neoadjuvant chemotherapy in breast cancer with F-FDG PET/CT: defining a clinical aim.

Correlation of high F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer.

Should FDG PET/CT be used for the initial staging of breast cancer?

Prognostic Impact of Stromal Immune Infiltration before and after Neoadjuvant Chemotherapy (NAC) in Triple Negative Inflammatory Breast Cancers (TNIBC) Treated with Dose-Dense Dose-Intense NAC.

Distinct tumor protein p53 mutants in breast cancer subgroups.

Estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast tumors: early prediction of chemosensitivity with (18)F-fluorodeoxyglucose positron emission tomography/computed tomography during neoadjuvant chemotherapy.

Estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast tumors.

Negative Relationship between Post-Treatment Stromal Tumor-Infiltrating Lymphocyte (TIL) and Survival in Triple-Negative Breast Cancer Patients Treated with Dose-Dense Dose-Intense NeoAdjuvant Chemotherapy.

Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15.

Unveiling Neoadjuvant Therapy: Insights and Outlooks for HER2-Positive Early Breast Cancer.

Neoadjuvant Therapy: Current Landscape and Future Horizons for ER-Positive/HER2-Negative and Triple-Negative Early Breast Cancer.

Prospective analysis of the impact of VEGF-A gene polymorphisms on the pharmacodynamics of bevacizumab-based therapy in metastatic breast cancer patients.

Final results of the double-blind placebo-controlled randomized phase 2 LOTUS trial of first-line ipatasertib plus paclitaxel for inoperable locally advanced/metastatic triple-negative breast cancer.

Prognostic Impact of <sup>18</sup>FDG-PET-CT Findings in Clinical Stage III and IIB Breast Cancer.

Breast cancer incidence and hormone replacement therapy: Results from the MISSION study, prospective phase.

Breast cancer in postmenopausal women with and without hormone replacement therapy: Preliminary results of the MISSION study

Actionability of HER2-amplified circulating tumor cells in HER2-negative metastatic breast cancer: the CirCe T-DM1 trial.

Expression of amphiregulin and epidermal growth factor receptor in human breast cancer: analysis of autocriny and stromal-epithelial interactions.